Hematology

Sepsis associated with one in five deaths globally

Metabolic syndrome associated with increased risk of blood clot recurrence

Heart transplants from donors with hepatitis C may be safe

Simple technique effective in preventing maternal death from hemorrhaging

Study shows persistent organic pollutants in maternal blood linked to smaller fetal size

Scientists visualize competition between healthy, dysfunctional platelets

CAR T-cell therapy effective for relapsed mantle cell lymphoma patients

Aspirin’s health benefits under scrutiny

Fresh red blood cell transfusions do not help critically ill children more than older cells

Grifols introduces its first plasma protein-based biosurgery product

Respiration key to increase oxygen in the brain

Study finds improving blood vessel health in the brain may help combat Alzheimer’s disease

Researchers identify protein that governs human blood stem cell self-renewal

Digital sepsis monitoring system helps save lives and improves care

First targeted therapy to treat complication of sickle cell disease

FDA approves first therapy to treat patients with rare blood disorder

Diversity of Plasmodium falciparum across Sub-Saharan Africa

Beckman Coulter receives BARDA funding to develop algorithm to aid in the early detection of sepsis

Hygiene products associated with presence of chemicals in women’s blood

How opt-out organ donation could affect U.S. waiting lists

NIH researchers create new viral vector for improved gene therapy in sickle cell disease

AABB and IFATS launch first standards for adipose-based therapies

Sysmex America and LabCorp extend hematology automation agreement

Figure 1. Blood coagulation cascade, in response to injury via tissue factor (TF) / factor VII (FVII) activation. Hemophilia A (HA) is caused by deficiency in factor VIII (FVIII, shown as blue circle above). Hemophilia B (HB) is caused by deficiency in factor IX (FIX, shown as pink square above). Other abbreviations: factor XII (FXII), factor XI (FXI), factor X (FX), and factor V (FV).

New HA and HB therapies offer innovation for patients and expanded testing opportunities for laboratories

Red blood cell donor pregnancy history not linked to higher mortality in transfusion recipients

FDA recalls Beckman Coulter blood test analyzers due to risk of inaccurate platelet analyzing results